Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial - SUPPLEMENTARY MATERIAL

Published: 19 September 2024| Version 1 | DOI: 10.17632/pfsydwvcj2.1
Contributors:
Victoria P. Werth, Joan T. Merrill, Richard Furie, Thomas Dörner, Ronald van Vollenhoven, Peter Lipsky, Michael Weiswasser, Shimon Korish, Peter H. Schafer, Mark Stern, Stan Li, Nikolay Delev

Description

Supplementary materials for the Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: a randomized phase 2 clinical trial manuscript.

Files

Institutions

Bristol-Myers Squibb

Categories

Systemic Lupus Erythematosus, Lupus Erythematosus

Funding

Bristol-Myers Squibb

Licence